Amneal Pharmaceuticals earnings were -$13.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest AMRX earnings report on Mar 31, 2025 announced Q1 2025 earnings of $12.2M, down 139.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AMRX reported annual earnings of -$116.9M, with 39.2% growth. The next AMRX earnings date is Aug 7, 2025.
Amneal Pharmaceuticals Earnings Reports & History FAQ
What were Amneal Pharmaceuticals's earnings last quarter?
Amneal Pharmaceuticals (NASDAQ: AMRX) reported Q1 2025 earnings per share (EPS) of $0.04, up 113.33% year over year. Total AMRX earnings for the quarter were $12.20 million. In the same quarter last year, Amneal Pharmaceuticals's earnings per share (EPS) was -$0.30.
The next AMRX earnings date is Invalid Date. Add AMRX to your watchlist to be reminded of Amneal Pharmaceuticals's next earnings date.
Is Amneal Pharmaceuticals profitable or losing money?
As of the last Amneal Pharmaceuticals earnings report, Amneal Pharmaceuticals is currently losing money. Amneal Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$13.05 million, a 92.27% decrease year over year.
What was AMRX's earnings growth in the past year?
As of Amneal Pharmaceuticals's earnings date in Q3 2025, Amneal Pharmaceuticals's earnings has grown year over year. AMRX earnings in the past year totalled -$13.05 million.
What are Amneal Pharmaceuticals's earnings expectations?
The current EPS estimate for Amneal Pharmaceuticals's earnings report in Invalid Date is $0.17.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.